PetMed Express Inc. (PETS)
| Bid | 4 |
| Market Cap | 87.27M |
| Revenue (ttm) | 247.27M |
| Net Income (ttm) | 357.38K |
| EPS (ttm) | 0.01 |
| PE Ratio (ttm) | 422.5 |
| Forward PE | -157.33 |
| Analyst | Hold |
| Ask | 4.25 |
| Volume | 239,860 |
| Avg. Volume (20D) | 261,318 |
| Open | 4.00 |
| Previous Close | 4.04 |
| Day's Range | 4.04 - 4.25 |
| 52-Week Range | 2.90 - 6.85 |
| Beta | 0.79 |
About PETS
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescripti...
Analyst Forecast
According to 2 analyst ratings, the average rating for PETS stock is "Hold." The 12-month stock price forecast is $3.5, which is a decrease of -17.16% from the latest price.
Stock Forecasts
1 month ago · proactiveinvestors.co.uk
Pets at Home to sell first pet food made from 'cultivated meat'Pets at Home Group PLC (LSE:PETS) said it is the first company in the world to sell lab-grown meat for pet food, after 'Chick Bites' went on sale in limited release at one of its stores, in west Londo...
